|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 18777520.0 (espacenet) (Federated) (European Patent Register), 20180330 | | Patent/reg. no. and date | DK/EP 3600282, 20250910 | | Publication date | 20200205 | | Priority no. and date | US 201762480226 P, 20170331 | | EP pub. no. and date |
EP 3600282 20200205 | | Effective date | | | Applicant/owner | Corcept Therapeutics Incorporated, 101 Redwood Shores Parkway
Redwood City, CA 94065, US | | Applicant ref. no. | V2510-028-DK | | Inventor | HUNT, Hazel, 149 Commonwealth Drive
Menlo Park
California 94025, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/337 (2006.01) , A61K 31/4745 (2006.01) , A61K 31/513 (2006.01) , A61K 31/7068 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) | | Title | GLUCOKORTIKOIDRECEPTORMODULATORER TIL BEHANDLING AF LIVMODERHALSCANCER | | Int. application no. | US2018025547 | | Int. publication no. | WO2018183947 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
